Introduction: Lupus nephritis (LN) is one of the most common and serious ... Introdução: Nefrite lúpica (NL) é uma das manifestações mais comuns e graves do lúpus eritematoso sistêmico (LES), ...

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

A recent survey was conducted by TEAM LEWIS on behalf of the Lupus Foundation of America (LFA) to explore American’s awareness and knowledge of lupus. 1,000 individuals in the US, ages 18 or older, ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...

DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according to a speaker at the Congress of Clinical Rheumatology ...

Lupus is a disease that tends to be more frequent and more severe in people of non-European ancestry. As such, treatment may work less effectively in these populations. And there are multiple ...

Lupus patients, advocates, and medical experts gathered Thursday for the observation of World Lupus Day on May 10 to put the spotlight on the challenges of living with the chronic autoimmune disease ...

The Lupus Awareness Walk and Health Fair is set for Saturday, May 3, at Granger Park in LaGrange. Registration begins at 8 a.m. with the walk starting at 9 a.m. Harris encourages anyone to come ...

The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to FT819, a cell therapy Fate Therapeutics is developing to treat lupus. An RMAT ...

Ty Majeski faces personal challenges with his wife Ali’s lupus diagnosis in 2023. Lupus, affecting 1.5 million Americans, involves serious organ damage. Majeski is committed to supporting Ali through ...

Join Drs Maureen McMahon and Michael Garshick as they discuss cardiovascular disease in patients with systemic lupus erythematosus, focusing on hidden risk and challenging clinical scenarios.